Health Care: MICHAEL J. FRIEDLANDER
EXECUTIVE DIRECTOR, FRALIN BIOMEDICAL RESEARCH INSTITUTE AT VTC; VICE PRESIDENT FOR HEALTH SCIENCES AND TECHNOLOGY, VIRGINIA TECH, ROANOKE
Published
Friedlander is among the top leaders in Virginia focused on growing the biomedical research industry.
Since he founded the Fralin Biomedical Research Institute at Virginia Tech Carilion a decade ago, the institute has doubled its lab facilities in Roanoke and expanded to new laboratories on the Children’s National Research & Innovation Campus in Washington, D.C. Today, the institute has more than 400 employees and trainees. Fralin’s biomedical research programs focus on solving leading causes of death and suffering in the United States, including cancer, brain disorders and heart disease.
Friedlander oversees $140 million in funded research projects. He also leads academic programs for medical, doctoral, graduate and undergraduate students at Virginia Tech.
In 2019, Friedlander was named a fellow for the American Association for the Advancement of Science, the world’s largest multidisciplinary scientific society. In 2016, he was named a distinguished scientist by the Society for Experimental Biology and Medicine. He also served as president for the society from 2011 to 2013.
